Open Medicine Institute

**Open Medicine Institute** The **Open Medicine Institute (OMI)**, founded in **2009**, functions as a research and service organization aiming to bridge gaps in healthcare through strategic utilization of information and biotechnology. The organization is involved in various activities, including running clinical trials, community-based research programs, health improvement initiatives, and offering core laboratory services to facilitate patients, physicians, and researchers. OMI's approach emphasizes providing patients with mobile-enabled tools to actively engage in managing their health and preventing diseases. OMI operates as a community benefits corporation (**B-corp**), with a primary focus on prioritizing patient welfare. The institute operates within the **Health Care** and **Health and Wellness** sectors. As of now, there is no publicly disclosed information related to the last investment received or the involved investors. However, OMI's commitment to leveraging information and biotechnology for the betterment of healthcare presents potential opportunities for investment in improving patient outcomes and advancing healthcare technology.

Overall, Open Medicine Institute presents a compelling proposition in the health and wellness domain by addressing healthcare gaps through research, data utilization, and patient empowerment. With its B-corp status, the institute's devotion to patient-centric solutions is evident, positioning it as a potential candidate for investment in advancing healthcare innovation and improving patient care outcomes.